MITIGATE-NeoBOMB1, a Phase I/IIa Study to Evaluate Safety, Pharmacokinetics, and Preliminary Imaging of (68)Ga-NeoBOMB1, a Gastrin-Releasing Peptide Receptor Antagonist, in GIST Patients - Gruber, L; Jimenez-Franco, LD; Decristoforo, C (J Nucl Med, 2020)
et al.